GTCR-backed Cole-Parmer buys ZeptoMetrix

Cole-Parmer, which is backed by GTCR, has acquired Buffalo, New York-based ZeptoMetrix, a life sciences developer and manufacturer of quality control standards and verification panels used in molecular diagnostic testing for infectious diseases.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this